In our article recently published in J Steroid Biochem Mol Biol – a collaboration with Tytgat Institute for Liver and Intestinal Research (Amsterdam UMC, University of Amsterdam), Hospital La Fe and Hospital Manises – we show that treatment with vitamin D increases levels of its receptor and attenuates the proliferation of fibroblasts in Crohn’s disease. The Vitamin D Receptor Taq I Polymorphism Is Associated With Reduced VDR and Increased PDIA3 Protein Levels in Human Intestinal Fibroblasts Fibroblast viewed through a miscroscope
Succinate Activates EMT in Intestinal Epithelial Cells through SUCNR1: A Novel Protagonist in Fistula Development.
Differential effects of biologics on psoriasis-related vascular inflammation and risk of thrombosis
p53 and p53-related Mediators PAI-1 and IGFBP-3 Are Downregulated in Peripheral Blood Mononuclear Cells of HIV-patients Exposed to NNRTI.
Diminished Vitamin D Receptor Protein Levels in Crohn’s Disease Fibroblasts: Effects of VD.
Gut is the journal of the British Society of Gastroenterology and is published by the BMJ Group.
Our group has published a new article in Journal of Crohns Colitis.
Mitophagy in human astrocytes treated with the antiretroviral drug Efavirenz: Lack of evidence or evidence of the lack.
Results of our line of research on inflammatory bowel disease have been published in Mucosal Immunology.
The journal Inflammatory Bowel Diseases (Crohn’s & Colitis Foundation) has published a new article by our group.